Fischer J, Hein L, Lüllmann-Rauch R, von Witzendorff B
Department of Pharmacology, University of Kiel, Germany.
Biochem J. 1996 Apr 15;315 ( Pt 2)(Pt 2):369-75. doi: 10.1042/bj3150369.
The immunomodulatory agent tilorone -2,7-bis-[2-(diethyl-amino)ethoxy]fluoren-9-one- and congeners are potent inducers of lysosomal storage of sulphated glycosaminoglycans (GAGs) in animals and cultured fibroblasts of animals and man. All potent inducers of GAG storage hitherto described are bisbasic polycyclic aromatic compounds. They are accumulated in lysosomes and disturb the degradation of GAGs, mainly dermatan sulphate. It has been proposed that the drugs cross-link the polyanionic GAG chains giving rise to undergradable drug-GAG complexes. This hypothesis implies that the bisbasic character of the drug molecules is essential for the side effect in question. In the present study, this was tested by comparing tilorone and its monobasic derivative (MT) with respect to (i) induction of GAG storage in cultured bovine corneal fibroblasts and (ii) physicochemical interactions with GAGs in vitro. The intralysosomal concentration of MT achieved after 1-3 days was of the same order of magnitude as previously shown for tilorone. Nevertheless, under conditions that did not enhance the secretion of a lysosomal enzyme (beta-hexosaminidase, EC 3.2.1.52), the ability of MT to cause storage of [35S]GAGs was significantly lower than that of tilorone. Morphological observations showed that MT was much more potent in causing lysosomal storage of polar lipids than of GAGs. CD spectroscopy with tilorone revealed that the presence of GAGs caused the primarily achiral drug molecules to display CD. This suggested a helical orientation of the tilorone molecules within GAG-drug complexes, and short intermolecular distances which allowed electronic coupling of the aromatic ring systems of adjacent drug molecules. In contrast, MT failed to display any induced optical activity, indicating the absence of highly ordered GAG-drug complexes. In conclusion, the present results show that the substitution of the planar aromatic ring system with two basic side chains is essential for the high potency of tilorone in inducing lysosomal GAG storage. This is paralleled by, and presumably causally related to, strong physicochemical interactions with GAGs.
免疫调节剂泰洛龙(2,7 - 双 - [2 - (二乙氨基)乙氧基]芴 - 9 - 酮)及其同系物是动物以及人和动物的培养成纤维细胞中硫酸化糖胺聚糖(GAGs)溶酶体储存的有效诱导剂。迄今所描述的所有GAG储存的有效诱导剂均为二元多环芳烃化合物。它们在溶酶体中积累并干扰GAGs的降解,主要是硫酸皮肤素。有人提出,这些药物使多阴离子GAG链交联,从而产生不可降解的药物 - GAG复合物。该假说意味着药物分子的二元特性对于所讨论的副作用至关重要。在本研究中,通过比较泰洛龙及其一元衍生物(MT)在以下方面进行了测试:(i)在培养的牛角膜成纤维细胞中诱导GAG储存,以及(ii)在体外与GAGs的物理化学相互作用。1 - 3天后MT在溶酶体内的浓度达到与先前泰洛龙所示相同的数量级。然而,在不增强溶酶体酶(β - 己糖胺酶,EC 3.2.1.52)分泌的条件下,MT导致[35S]GAGs储存的能力明显低于泰洛龙。形态学观察表明,MT在引起极性脂质的溶酶体储存方面比引起GAGs的溶酶体储存更有效。对泰洛龙进行圆二色光谱分析表明,GAGs的存在导致原本无手性的药物分子呈现圆二色性。这表明在GAG - 药物复合物中泰洛龙分子呈螺旋取向,并且分子间距离短,使得相邻药物分子的芳香环系统能够进行电子耦合。相比之下,MT未能显示任何诱导的光学活性,表明不存在高度有序的GAG - 药物复合物。总之,目前的结果表明,用两个碱性侧链取代平面芳香环系统对于泰洛龙在诱导溶酶体GAG储存方面的高效性至关重要。这与与GAGs的强烈物理化学相互作用并行,并且可能与之因果相关。